enquiry@dsij.in |+91 9240904920
SENSEX-307.24
76,957.27-0.4%

Birlasoft margins stay resilient as deal conversion remains crucial for revenue recovery

Birlasoft Ltd.

Broker Recommendation:

HOLD

Reco. Price

₹312

CMP

₹291.15

Target

₹300

Downside

3.85%

Investment View

ICICI Direct Research’s July 29, 2026 result update on Birlasoft Limited retains a HOLD rating. The broker sees resilient profitability and improving net-new deal wins, but weak near-term revenue visibility and turnaround execution risks keep the risk-reward balanced.

Birlasoft is the global technology services division of the CKA Birla Group and operates across Manufacturing, BFSI, Energy and Utilities, and Lifesciences.

Q1 FY27 Financial Performance

Metric Q1 FY27 Sequential change Year-on-year change
Revenue US$145.2 million / Rs 1,379.4 crore Constant-currency revenue: +0.3%; rupee revenue: +2.3% Constant-currency revenue: -3%
EBITDA Rs 222.8 crore Margin declined 233 bps Margin increased 379 bps
EBITDA margin 16.1% Down from the previous quarter Up from the year-ago period
PAT Rs 161 crore -8.5% +51.3%

The sequential EBITDA-margin decline reflected the absence of around 170 basis points of one-off benefits in Q4 FY26 and continued investment in sales and demand capabilities. These factors were partly offset by operational efficiencies.

Business and Segment Trends

Operational trends were mixed. In US dollar terms, Rest of World, which represented 17.1% of revenue, grew 6.8% sequentially, while the Americas, representing 82.9% of revenue, declined 1.4%.

Vertical / geography Revenue contribution Sequential growth
Rest of World 17.1% +6.8%
Americas 82.9% -1.4%
BFSI 25.3% +5.0%
Lifesciences and Services 19.6% +2.0%
Manufacturing 37.6% -3.7%
Energy and Utilities 17.5% -1.2%

Management expects BFSI and Lifesciences momentum to remain strong. Manufacturing weakness is expected to persist for some time, while Energy and Utilities may remain soft for another quarter before improving from Q3 FY27.

Deal Wins and Revenue Visibility

Total contract value (TCV) was US$169 million in Q1 FY27, down 18.8% sequentially but up 19.9% year on year. Net-new TCV was US$57 million, representing around 34% of total TCV.

Management said deal tenures remain healthy at around 18 to 24 months, with no material movement towards shorter projects. A growing share of deals carries an AI component. Birlasoft won strategic AI-related engagements with a major US financial-services player, a European banking group and a pharma and MedTech company.

Management expects H1 FY27 deal signings to improve meaningfully year on year and FY27 signings to exceed FY26 levels.

Margin Outlook and Strategic Investments

Management reiterated a sustainable EBITDA-margin aspiration of more than 15%. July wage hikes carry a gross impact of around 170 to 200 basis points. Productivity actions are expected to offset a significant portion of this impact, leaving roughly half of the effect to flow into Q2 margins.

Birlasoft is investing in agentic AI, Cogito, Lynx test engineering and Sigma for agentic AIOps and application-management services. Cogito’s MVP has been demonstrated to more than 15 clients, and more than 25% of code is generated using agentic AI tools.

  • Headcount declined by 306 sequentially to 11,057.
  • Last-twelve-month attrition improved by around 130 basis points to 11.7%.
  • Sales capacity is expected to expand by 30% to 40% by mid-FY27.

Estimates and Valuation

ICICI Direct expects US dollar revenue to grow at a 2.5% CAGR over FY26 to FY28E. The broker raised its FY27E revenue, EBITDA and PAT estimates by 4.8%, 8.4% and 8.7%, respectively. FY28E revenue, EBITDA and PAT estimates were raised by 3.8%, 7.1% and 5.9%, respectively.

Estimate FY27E FY28E
EBITDA margin assumption 16.0% 16.1%

The Rs 300 target price is based on 12 times FY28E EPS, reduced from 17 times previously to reflect sector derating. The current market price was Rs 312 at the time of the report.

Key Risks and Catalysts

  • Key risks: Delayed revenue and margin recovery.
  • Potential upside: Faster-than-expected pipeline growth and deal conversion could improve the outlook.
View / Download Original Research Report

Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.